EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for MRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.965
March 31, 2026 -3.40
December 31, 2025 -2.107
September 30, 2025 -0.5128
June 30, 2025 -2.126
March 31, 2025 -2.516
December 31, 2024 -2.909
September 30, 2024 0.0326
June 30, 2024 -3.331
March 31, 2024 -3.076
December 31, 2023 0.5494
September 30, 2023 -9.528
June 30, 2023 -3.622
March 31, 2023 0.1951
December 31, 2022 3.617
September 30, 2022 2.532
June 30, 2022 5.243
March 31, 2022 8.584
Date Value
December 31, 2021 11.29
September 30, 2021 7.680
June 30, 2021 6.450
March 31, 2021 2.840
December 31, 2020 -0.6869
September 30, 2020 -0.592
June 30, 2020 -0.3067
March 31, 2020 -0.3518
December 31, 2019 -0.3715
September 30, 2019 -0.3725
June 30, 2019 -0.4099
March 31, 2019 -0.4032
December 31, 2018 -0.4383
September 30, 2018 -0.2638
June 30, 2018 -0.2826
March 31, 2018 -0.2279
December 31, 2017 -0.1244
September 30, 2017 -0.2051

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
BioNTech SE -3.799
Kailera Therapeutics, Inc. -0.8587
Sarepta Therapeutics, Inc. -0.0464
Replimune Group, Inc. -0.7202
Intellia Therapeutics, Inc. -0.7989